NRC News and Press, National Research Corporation From 03/07/23

MALVERN, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, today announce...

MALVERN, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced criteria changes...

LINCOLN, Neb., March 02, 2023 (GLOBE NEWSWIRE) -- NRC Health , the recognized leader and partner in patient experience improvement, is the first in the industry to seamlessly integrate patient-specific experience insights directly into the EHR to support care teams in understanding the un...

MALVERN, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its first of seve...

MALVERN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it pla...

MALVERN, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their parti...

Summary National Research Corporation came in with a strong set of Q4 and full-year numbers. Profitability characteristics to continue generating long-term value at incrementally higher rates of investment return. Retaining buy, $64 long-term target. Investment summary ...

MALVERN, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that Sara G...

LINCOLN, Neb., Feb. 15, 2023 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, released its 2023 Experience Perspective and trends report today. The report captures key data and ins...

National Research Corporation (NRC) Q4 2022 Earnings Conference Call February 15, 2023, 11:00 am ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants George D'Angelo - Alpine Peaks Capital Presentation O...